Proto Labs(PRLB)
Search documents
Proto Labs(PRLB) - 2022 Q2 - Earnings Call Transcript
2022-08-06 11:49
Proto Labs, Inc. (NYSE:PRLB) Q2 2022 Results Earnings Conference Call August 5, 2022 8:30 AM ET Company Participants Jason Frankman - Vice President and Corporate Controller Robert Bodor - President and Chief Executive Officer Dan Schumacher - Chief Financial Officer Conference Call Participants Brian Drab - William Blair Jim Ricchiuti - Needham & Company Greg Palm - Craig-Hallum Capital Group Operator Greetings. And welcome to Proto Labs Second Quarter 2022 Earnings Conference Call. At this time, all parti ...
Proto Labs(PRLB) - 2022 Q2 - Quarterly Report
2022-08-05 16:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35435 Proto Labs, Inc. (Exact name of registrant as specified in its charter) Minnesota 41-1939628 (State or o ...
Proto Labs(PRLB) - 2022 Q1 - Earnings Call Transcript
2022-05-06 16:47
Proto Labs, Inc. (NYSE:PRLB) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Jason Frankman - Vice President, Corporate Controller Robert Bodor - President, Chief Executive Officer Daniel Schumacher - Interim Chief Financial Officer Conference Call Participants Brian Drab - William Blair Danny Eggerichs - Craig Hallum Jim Ricchiuti - Needham & Co. Ben Rose - Battle Road Research Operator Greetings and welcome to Proto Labs Q1 2022 Earnings Conference Call. At this time, all part ...
Proto Labs(PRLB) - 2022 Q1 - Quarterly Report
2022-05-06 16:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35435 Proto Labs, Inc. (Exact name of registrant as specified in its charter) Minnesota 41-1939628 (State or ...
Proto Labs(PRLB) - 2021 Q4 - Annual Report
2022-02-18 16:31
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35435 Proto Labs, Inc. (Exact name of Registrant as specified in its charter) Minnesota 41-193962 ...
Proto Labs(PRLB) - 2021 Q4 - Earnings Call Transcript
2022-02-11 16:55
Proto Labs Inc. (NYSE:PRLB) Q4 2021 Earnings Conference Call February 11, 2021 8:30 AM ET Company Participants Rob Bodor - President, Chief Executive Officer Dan Schumacher - Chief Financial Officer (interim) Jason Frankman - Vice President, Corporate Controller Conference Call Participants Brian Drab - William Blair Greg Palm - Craig Hallum Jim Ricchiuti - Needham & Co. Jared Maymon - Berenberg Capital Ben Rose - Battle Road Research Operator Greetings. Welcome to Proto Labs Fourth Quarter 2021 Earnings C ...
Proto Labs(PRLB) - 2022 Q4 - Earnings Call Presentation
2022-02-11 15:06
Earnings Presentation Q4 and FY 2021 ▸February 11, 2022 1 Safe Harbor ▸ These slides and accompanying oral presentation may contain forward-looking statements. These statements relate to future events or to future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied ...
Proto Labs(PRLB) - 2021 Q3 - Quarterly Report
2021-11-02 20:10
Financial Performance - Revenue for the three months ended September 30, 2021, was $125.34 million, a 16.5% increase from $107.50 million in the same period of 2020[12] - Net income for the three months ended September 30, 2021, was $4.84 million, a decrease of 67.1% compared to $14.70 million in the same period of 2020[12] - Gross profit for the three months ended September 30, 2021, was $55.32 million, compared to $54.64 million in the prior year, reflecting a slight increase[12] - Total revenue for the nine months ended September 30, 2021, was $364,516,000, up 10.7% from $329,187,000 in the same period of 2020[71] - Net income for the nine months ended September 30, 2021, was $21,462,000, compared to $41,288,000 for the same period in 2020, representing a decrease of 48.0%[19] Expenses - Operating expenses increased to $48.40 million for the three months ended September 30, 2021, from $36.97 million in the same period of 2020, representing a 30.9% rise[12] - Research and development expenses rose to $10.61 million for the three months ended September 30, 2021, compared to $7.92 million in the prior year, reflecting a 33.8% increase[12] - Stock-based compensation expense for the nine months ended September 30, 2021, was $15,539,000, compared to $10,617,000 for the same period in 2020, reflecting an increase of 46.5%[19] - General and administrative expenses increased by $4.8 million, or 38.5%, largely due to higher professional service costs and expenses related to the acquisition of Hubs[102] Assets and Liabilities - Total assets as of September 30, 2021, were $930.31 million, up from $744.20 million as of December 31, 2020, indicating a growth of 25.0%[9] - Total liabilities increased to $105.69 million as of September 30, 2021, from $99.85 million at the end of 2020, representing a 5.8% increase[9] - The company’s cash and cash equivalents decreased to $47.80 million as of September 30, 2021, from $127.60 million as of December 31, 2020, a decline of 62.6%[9] Acquisition - The company acquired 3D Hubs, Inc. for a total consideration of $294.1 million, which included $127.4 million in cash and $166.7 million in common stock[27] - Goodwill increased by $281.8 million during the nine months ended September 30, 2021, due to the acquisition of Hubs, resulting in a total goodwill balance of $404.2 million[34] - Total assets acquired in the Hubs acquisition were valued at $316,251,000, with net assets acquired amounting to $294,122,000[32] Market Performance - Unique product developers served increased by 24.8% to 23,457 during the three months ended September 30, 2021, compared to the same period in 2020[82] - Revenue from CNC Machining increased by 31.8% to $43.7 million, while Injection Molding revenue rose by 8.3% to $57.7 million for the three months ended September 30, 2021[97] Taxation - The effective income tax rate for the three months ended September 30, 2021, was 31.5%, an increase of 11.4% compared to the same period in 2020[11] - The Company recorded an income tax provision of $2.2 million for the three months ended September 30, 2021, down from $3.7 million in the same period of 2020[11] Cash Flow - The company reported a net cash provided by operating activities of $32,225,000 for the nine months ended September 30, 2021, down from $82,375,000 for the same period in 2020, a decrease of 60.9%[19] - Cash used in investing activities was $98.3 million during the nine months ended September 30, 2021, primarily for the acquisition of Hubs and capital asset purchases[123] Stock and Compensation - As of September 30, 2021, there were 248,548 stock options outstanding with a weighted average exercise price of $98.84, up from 229,531 options at December 31, 2020[55] - Unrecognized compensation expense related to unvested stock options was $5.4 million as of September 30, 2021, expected to be recognized over a weighted-average period of 2.8 years[57] - Restricted stock awards increased to 351,774 shares at September 30, 2021, with an average fair value of $117.51 per share[59]
Proto Labs(PRLB) - 2021 Q3 - Earnings Call Presentation
2021-11-01 14:42
Financial Performance - Record revenue reached $125.3 million, a 16.6% year-over-year increase[8] - Non-GAAP EPS decreased by 47.5% year-over-year to $0.35[8] - Revenue increased by 1.9% quarter-over-quarter to $125.3 million[10] - Non-GAAP EPS decreased by 9.3% quarter-over-quarter to $0.35[11] - Non-GAAP gross margin decreased by 680 bps year-over-year to 44.9%[38] - Non-GAAP operating margin decreased by 1060 bps year-over-year to 10.2%[38] Revenue by Service - CNC Machining revenue increased by 32% year-over-year to $43.7 million[19] - 3D Printing revenue increased by 14% year-over-year to $18.6 million[17] - Injection Molding revenue increased by 8% year-over-year to $57.7 million[15] - Sheet Metal revenue increased by 22% year-over-year to $4.9 million[21] Revenue by Region - Americas revenue increased by 17% year-over-year to $100.1 million[32] - Europe revenue increased by 17% year-over-year to $22.2 million[32] - Japan revenue increased by 2% year-over-year to $3.1 million[32]
Proto Labs(PRLB) - 2021 Q3 - Earnings Call Transcript
2021-10-28 17:27
Proto Labs, Inc. (NYSE:PRLB) Q3 2021 Earnings Conference Call October 28, 2021 8:30 AM ET Company Participants Dan Schumacher - Investor Relations Rob Bodor - President and Chief Executive Officer John Way - Chief Financial Officer Conference Call Participants Brian Drab - William Blair Danny Eggerichs - Craig-Hallum Operator Greetings and welcome to the Protolabs Third Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to i ...